1. Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance
    Supriya Bevinakoppamath et al, 2022, Frontiers in Pharmacology CrossRef
  2. miR-497-5p Enhances the Chemosensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin via Targeting of the CDCA4 Gene
    Nasir Azam et al, 2022, Journal of Biomedical Research & Environmental Sciences CrossRef
  3. Identification of the circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Bioinformatics Analysis
    Jiancheng Lv et al, 2021, International Journal of Genomics CrossRef
  4. Genetic architecture and heritability of early‐life telomere length in a wild passerine
    Michael Le Pepke et al, 2022, Molecular Ecology CrossRef
  5. CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
    Yixiang Zhang et al, 2020, Frontiers in Oncology CrossRef
  6. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy
    Chenglin Li et al, 2023, Frontiers in Immunology CrossRef
  7. Analysis of the Expression of Cell Division Cycle-Associated Genes and Its Prognostic Significance in Human Lung Carcinoma: A Review of the Literature Databases
    Chongxiang Chen et al, 2020, BioMed Research International CrossRef
  8. Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin
    Alev Tascioglu Aliyev et al, 2021, Molecules CrossRef
  9. Potential Applications of NRF2 Inhibitors in Cancer Therapy
    Emiliano Panieri et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  10. Delineating the twin role of autophagy in lung cancer
    Shaoqin Zhang et al, 2023, Biologia Futura CrossRef
  11. A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors
    Hui Fang et al, 2022, Frontiers in Immunology CrossRef
  12. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
    Jianlong Tan et al, 2022, Frontiers in Oncology CrossRef